Histochemistry and Cell Biology, 2021 · DOI: 10.1007/s00418-021-01985-y · Published: May 8, 2021
This study investigates scleral fibroblasts, which maintain the collagenous extracellular matrix of the sclera, and their response to inflammation. The researchers used scleras from mice expressing a fluorescent marker (GFP) under the control of the scleraxis gene, a marker for tendon cells, to identify and study these cells. The study found that scleral cells expressing scleraxis responded to inflammatory stimulation by upregulating inflammatory and fibrotic markers, and that dexamethasone, a corticosteroid, could reduce this response.
The study provides insights into the cellular mechanisms underlying scleral inflammation, potentially leading to better understanding and treatment of scleritis.
Identifying the specific inflammatory and fibrotic markers upregulated in scleral cells could lead to the development of targeted therapies.
The ex vivo model can be used to test the efficacy of various drugs, including corticosteroids, in reducing scleral inflammation.